Global Edible Vaccine 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR122400387

Publication Date:

December 3, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Edible Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The report includes an overview of the development of the Edible Vaccine industry chain, the market status of Medical Care (Inactivated Vaccines, Others), Livestock (Inactivated Vaccines, Others), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Edible Vaccine.
Regionally, the report analyzes the Edible Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Edible Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Edible Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Edible Vaccine industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Inactivated Vaccines, Others).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Edible Vaccine market.
Regional Analysis: The report involves examining the Edible Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Edible Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Edible Vaccine:
Company Analysis: Report covers individual Edible Vaccine players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Edible Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Medical Care, Livestock).
Technology Analysis: Report covers specific technologies relevant to Edible Vaccine. It assesses the current state, advancements, and potential future developments in Edible Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Edible Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Edible Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Inactivated Vaccines
Others
麻豆原创 segment by Application
Medical Care
Livestock
Others
麻豆原创 segment by players, this report covers
GSK
Sanofi
Merck
Merial
Santa Cruz Animal Health
Ceva
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Edible Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Edible Vaccine, with revenue, gross margin and global market share of Edible Vaccine from 2019 to 2024.
Chapter 3, the Edible Vaccine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Edible Vaccine market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Edible Vaccine.
Chapter 13, to describe Edible Vaccine research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Edible Vaccine
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Edible Vaccine by Type
1.3.1 Overview: Global Edible Vaccine 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Edible Vaccine Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Inactivated Vaccines
1.3.4 Others
1.4 Global Edible Vaccine 麻豆原创 by Application
1.4.1 Overview: Global Edible Vaccine 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Medical Care
1.4.3 Livestock
1.4.4 Others
1.5 Global Edible Vaccine 麻豆原创 Size & Forecast
1.6 Global Edible Vaccine 麻豆原创 Size and Forecast by Region
1.6.1 Global Edible Vaccine 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Edible Vaccine 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Edible Vaccine 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Edible Vaccine 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Edible Vaccine 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Edible Vaccine 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Edible Vaccine 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Edible Vaccine Product and Solutions
2.1.4 GSK Edible Vaccine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 GSK Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Edible Vaccine Product and Solutions
2.2.4 Sanofi Edible Vaccine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Edible Vaccine Product and Solutions
2.3.4 Merck Edible Vaccine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Merck Recent Developments and Future Plans
2.4 Merial
2.4.1 Merial Details
2.4.2 Merial Major Business
2.4.3 Merial Edible Vaccine Product and Solutions
2.4.4 Merial Edible Vaccine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Merial Recent Developments and Future Plans
2.5 Santa Cruz Animal Health
2.5.1 Santa Cruz Animal Health Details
2.5.2 Santa Cruz Animal Health Major Business
2.5.3 Santa Cruz Animal Health Edible Vaccine Product and Solutions
2.5.4 Santa Cruz Animal Health Edible Vaccine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Santa Cruz Animal Health Recent Developments and Future Plans
2.6 Ceva
2.6.1 Ceva Details
2.6.2 Ceva Major Business
2.6.3 Ceva Edible Vaccine Product and Solutions
2.6.4 Ceva Edible Vaccine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Ceva Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Edible Vaccine Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Edible Vaccine by Company Revenue
3.2.2 Top 3 Edible Vaccine Players 麻豆原创 Share in 2023
3.2.3 Top 6 Edible Vaccine Players 麻豆原创 Share in 2023
3.3 Edible Vaccine 麻豆原创: Overall Company Footprint Analysis
3.3.1 Edible Vaccine 麻豆原创: Region Footprint
3.3.2 Edible Vaccine 麻豆原创: Company Product Type Footprint
3.3.3 Edible Vaccine 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Edible Vaccine Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Edible Vaccine 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Edible Vaccine Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Edible Vaccine 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Edible Vaccine Consumption Value by Type (2019-2030)
6.2 North America Edible Vaccine Consumption Value by Application (2019-2030)
6.3 North America Edible Vaccine 麻豆原创 Size by Country
6.3.1 North America Edible Vaccine Consumption Value by Country (2019-2030)
6.3.2 United States Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Edible Vaccine Consumption Value by Type (2019-2030)
7.2 Europe Edible Vaccine Consumption Value by Application (2019-2030)
7.3 Europe Edible Vaccine 麻豆原创 Size by Country
7.3.1 Europe Edible Vaccine Consumption Value by Country (2019-2030)
7.3.2 Germany Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Edible Vaccine Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Edible Vaccine Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Edible Vaccine 麻豆原创 Size by Region
8.3.1 Asia-Pacific Edible Vaccine Consumption Value by Region (2019-2030)
8.3.2 China Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Edible Vaccine Consumption Value by Type (2019-2030)
9.2 South America Edible Vaccine Consumption Value by Application (2019-2030)
9.3 South America Edible Vaccine 麻豆原创 Size by Country
9.3.1 South America Edible Vaccine Consumption Value by Country (2019-2030)
9.3.2 Brazil Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Edible Vaccine Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Edible Vaccine Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Edible Vaccine 麻豆原创 Size by Country
10.3.1 Middle East & Africa Edible Vaccine Consumption Value by Country (2019-2030)
10.3.2 Turkey Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Edible Vaccine 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Edible Vaccine 麻豆原创 Drivers
11.2 Edible Vaccine 麻豆原创 Restraints
11.3 Edible Vaccine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Edible Vaccine Industry Chain
12.2 Edible Vaccine Upstream Analysis
12.3 Edible Vaccine Midstream Analysis
12.4 Edible Vaccine Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

GSK
Sanofi
Merck
Merial
Santa Cruz Animal Health
Ceva

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.